Esas Private Equity

Esas Private Equity is the direct investment arm of Esas Holding, a Turkey-based family investment group with international operations. The firm makes buyout and growth equity investments in cash-generative, growth-oriented companies across multiple sectors rather than operating as a drug developer or healthcare products company. Its international portfolio has included healthcare and pharma-related investments such as SERB, Axplora, symplr, UrgentMED, Minafin, and Tri-Imaging Solutions, alongside investments in technology, consumer, and industrial businesses. For biotech and pharma diligence purposes, Esas Private Equity is best understood as a financial sponsor and owner/investor in healthcare assets, not as a life sciences operating company with its own therapeutic pipeline.